Jewell et al. reported a decrease in the synthesis of IL-17 in a 4T1 mouse metastasis model upon in vivo treatment with an endothelin-1 antagonist, associated with a reduction in tumor mass and bone metastasis [47]. The gene discussed is EDN1; the disease is neoplasm.